Logo image of PHXM

PHAXIAM Therapeutics SA (PHXM) Stock Analyst Earnings Estimates

NASDAQ:PHXM - Nasdaq - US29604W2070 - ADR - Currency: USD

3.1  -0.02 (-0.64%)

After market: 3.1 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
PHXM revenue by date.PHXM revenue by date.
3.718M
-42.45%		4.18M
12.43%		6.648M
59.04%
-100.00%
EBITDA
YoY % growth
PHXM ebitda by date.PHXM ebitda by date.
-63.841M
-14.79%		-51.138M
19.90%		-22.528M
55.95%		-25.806M
-14.55%		-19.89M
22.92%		-20.4M
-2.56%		N/A
EBIT
YoY % growth
PHXM ebit by date.PHXM ebit by date.
-68.832M
-14.14%		-56.515M
17.89%		-27.147M
51.96%		-26.418M
2.69%		-20.502M
22.39%		-21.012M
-2.49%		-21.322M
-1.48%
Operating Margin
PHXM operating margin by date.PHXM operating margin by date.
-1,851.32%-1,352.03%-408.35%N/AN/AN/AN/A
EPS
YoY % growth
PHXM eps by date.PHXM eps by date.
N/A
-5.11%		N/A
17.43%		N/A
51.41%		-1.62
77.73%		-0.95
41.29%		-0.73
22.94%		N/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23
EPS
Q2Q % growth		-0.14
86.11%
Revenue
Q2Q % growth		N/A
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		N/A

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth
93.89%		-0.12%
Q2 2023
Q2Q % growth
80.53%		-0.12%
Q1 2023
Q2Q % growth
57.45%		-1.10%
Q4 2022
Q2Q % growth
62.50%		-0.99%
Q3 2022
Q2Q % growth
38.98%		-1.99%
Q2 2022
Q2Q % growth		 -0.59
81.72%		-3.092.4980.74%
PHXM Yearly EPS VS EstimatesPHXM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -5 -10 -15
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 197K
-58.00%		%
Q2 2023
Q2Q % growth		 278K
-70.86%		%
Q1 2023
Q2Q % growth
-88.24%		299.88K%
Q4 2022
Q2Q % growth		 5.694M
272.16%		714K4.98M697.48%
Q3 2022
Q2Q % growth		 469K
-69.35%		%
Q2 2022
Q2Q % growth		 954K 2.55M-1.596M-62.59%
PHXM Yearly Revenue VS EstimatesPHXM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% -15.5% -0.34%
RevenueN/A N/A N/A N/A